Cosmos Net Receivables from 2010 to 2026

COSM Stock  USD 0.47  0.01  2.50%   
Cosmos Health Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to drop to about 14.5 M. During the period from 2010 to 2026, Cosmos Health Net Receivables quarterly data regression pattern had sample variance of 115.3 T and median of  4,943,051. View All Fundamentals
 
Net Receivables  
First Reported
2014-06-30
Previous Quarter
18.3 M
Current Value
19.6 M
Quarterly Volatility
11.1 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 14.2 M or Other Operating Expenses of 84.5 M, as well as many indicators such as Price To Sales Ratio of 0.22, Dividend Yield of 0.38 or PTB Ratio of 0.49. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
  
Build AI portfolio with Cosmos Stock
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
Evaluating Cosmos Health's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Cosmos Health's fundamental strength.

Latest Cosmos Health's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Cosmos Health over the last few years. It is Cosmos Health's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Cosmos Net Receivables Regression Statistics

Arithmetic Mean9,719,942
Geometric Mean1,918,340
Coefficient Of Variation110.46
Mean Deviation9,433,927
Median4,943,051
Standard Deviation10,736,291
Sample Variance115.3T
Range30M
R-Value0.78
Mean Square Error48.2T
R-Squared0.61
Significance0.0002
Slope1,657,847
Total Sum of Squares1844.3T

Cosmos Net Receivables History

202614.5 M
202518.3 M
202415.9 M
202319.8 M
202222.8 M
202130.1 M
202026.9 M

About Cosmos Health Financial Statements

Cosmos Health investors utilize fundamental indicators, such as Net Receivables, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables18.3 M14.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Will Health Care Providers & Services sector continue expanding? Could Cosmos diversify its offerings? Factors like these will boost the valuation of Cosmos Health. Projected growth potential of Cosmos fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Cosmos Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.77)
Revenue Per Share
2.196
Quarterly Revenue Growth
0.379
Return On Assets
(0.13)
Return On Equity
(0.64)
Investors evaluate Cosmos Health using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Cosmos Health's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Cosmos Health's market price to deviate significantly from intrinsic value.
It's important to distinguish between Cosmos Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cosmos Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Cosmos Health's market price signifies the transaction level at which participants voluntarily complete trades.